ERA-NET subsidy for translational research on human ovarian tumour
Peter Horvatovich, Analytical Biochemistry (Groningen Research institute of Pharmacy), received as consortium partner in TRANSCAN-2, ERA-NET research program 300.000 euro subsidy for translational research on human ovarian tumour heterogeneity to overcome recurrence and resistance to therapy. The project in collaboration with European partners and the labs of Kathrin Thedieck (UMCG), Marco Grzegorczyk (JBI) and Victor Guryev (UMCG) will allow to understand molecular heterogeneity of human primary and metastatic ovarian cancer and open new doors for better patient characterization and personalized treatment of this malignant cancer type, where patients have currently less than 45% of 5-years survival rate.
| Last modified: | 07 April 2016 11.41 a.m. |
More news
-
15 May 2019
Academy Medal for Trudy Dehue
Trudy Dehue, scientific sociologist, author and emeritus professor of the University of Groningen, will receive the Academy Medal from the Royal Netherlands Academy of Arts and Sciences (KNAW). The Academy Medal is awarded every other year to individuals...
-
15 May 2019
Van Rijn advice hits UG hard
The advice from the Van Rijn committee concerning the funding of higher education has heavy consequences for the UG as a broad-based classical university. The proposed redistribution of funds in favour of technical sciences is at the expense of degree...
-
14 May 2019
Number of children with type 1 diabetes doubled
The number of children who are annually diagnosed with type 1 diabetes has doubled over the last 30 years. This is one of the conclusions of the PhD thesis written by Angelien Spaans-Hummelink, who works as a paediatrician at the diabetes clinic at...